
    
      Participants were treated until DP, unacceptable toxicity, participant's refusal of further
      study treatment or for a maximum of 10 cycles. All participants were followed when on study
      treatment and after completion of study treatment during follow up period until death or the
      study cutoff date, whichever came first.
    
  